Rezdiffra (resmetirom) - Madrigal Pharma
Revuforj (revumenib) - Syndax Pharma
Crenessity (crinecerfont) - Neurocrine
Iqirvo (elafibranor) - Ipsen
Voydeya (danicopan) - AstraZeneca
Voranigo (vorasidenib) - Servier
Livdelzi (seladelpar) - Gilead
Miplyffa (arimoclomol) - Orphazyme, Zevra Therap
http://www.ncbi.nlm.nih.gov/pubmed/40430547
 
Chao Wang; Liyan Yang; Mingyu Sun; Xin Sun; Zhonglei Wang
 
May 28, 2025
 
Next